JSM 2012 Home

JSM 2012 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

Online Program Home

Activity Details

13 * ! Sun, 7/29/2012, 2:00 PM - 3:50 PM HQ-Sapphire MN
Increasing Clinical Program Success with Modeling and Simulation — Topic Contributed Papers
Biopharmaceutical Section
Organizer(s): Olga V Marchenko, Quintiles, Inc.
Chair(s): Olga V Marchenko, Quintiles, Inc.
2:05 PM Improving Clinical Study Design and Understanding via Modeling and Simulation Chyi-Hung Hsu, Janssen Pharmaceuticals, Inc. ; Jose Carlos Pinheiro, Johnson & Johnson ; Fei Chen, Janssen Pharmaceuticals, Inc.
2:25 PM Benefits of Model-Based Drug Development: A Rigorous Case Study Russell Reeve, Quintiles, Inc.
2:45 PM Utilizing Modeling and Simulation to Optimize Phase 2 for Decisionmaking Brenda Gaydos, Eli Lilly and Company
3:05 PM Improving Oncology Clinical Program by Use of Innovative Designs and Comparing via Simulations Joel Miller, Eli Lilly and Company/ImClone ; Tom Parke, Tessella Inc. ; Donald Berry, MD Anderson Cancer Center ; Olga V Marchenko, Quintiles, Inc. ; Inna Perevozskaya, Pfizer Inc. ; Yanping Wang, Eli Lilly and Company
3:25 PM Discussant: Martin Kimber, Tessella Inc.
3:45 PM Floor Discussion

2012 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.